Dr Hopkins is an experienced bio-pharmaceutical executive with over 20 years in corporate leadership roles with public biotechnology companies. He has an established track record in drug development of novel therapies with a particular focus in oncology, corporate strategy, business development and intellectual property.

Dr Hopkins is currently the Managing Director ex-USA at Zelira Therapeutics, a leading global company focused on clinical validation of medical cannabis. Prior to this, Dr Hopkins served as Chief Executive Officer at PharmAust where he oversaw clinical development of a novel cancer therapy for dogs and humans. He was also a co-founder of Phylogica, where, in addition to the CEO role, he served in variety of positions, including Chief Scientific Officer, and Chief Operating Officer where he led a team of over 25 scientists.

During his career, Dr. Hopkins and managed and overseen strategic alliances and licensing deals with multiple global pharmaceutical partners including J&J, Pfizer, Roche, Genentech, AstraZeneca/Medimmune, generated over $14 million in revenues and built strong proprietary pipelines.

Dr Hopkins is an author on over 30 peer reviewed publications and is an inventor on 17 patents and patent applications.

‍